P2Y12 Receptor Inhibitors: Integrating Ticagrelor into the Management of Acute Coronary Syndrome

Acute coronary syndrome (ACS) is a continuum of disease that includes non–ST-segment elevation ACS and ST-segment elevation myocardial infarction. The purpose of this article is to define the developing role of ticagrelor in ACS and compare it to currently available P2Y12 receptor inhibitors. While...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Annals of pharmacotherapy 2011-09, Vol.45 (9), p.1151-1156
Hauptverfasser:	Crouch, Michael A, Colucci, Vince J, Howard, Patricia A, Spinier, Sarah A
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - physiopathology Adenosine - adverse effects Adenosine - analogs & derivatives Adenosine - pharmacology Adenosine - therapeutic use Algorithms Dyspnea - chemically induced Humans Purinergic P2Y Receptor Antagonists - adverse effects Purinergic P2Y Receptor Antagonists - pharmacology Purinergic P2Y Receptor Antagonists - therapeutic use Receptors, Purinergic P2Y12 - drug effects Receptors, Purinergic P2Y12 - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!